(Q52552541)

3 May 2018

title

Elevated insulin, proinsulin and insulin-like growth factor-binding protein-1 in liver disease. (English)

1 reference

3 May 2018

1 reference

David L Hwang

1

1 reference

3 May 2018

Shiao-Ping Huang

series ordinal

2

1 reference

3 May 2018

Wuu-Shyang Lan

series ordinal

3

1 reference

3 May 2018

Phillip D K Lee

series ordinal

4

1 reference

3 May 2018

publication date

1 December 2003

1 reference

3 May 2018

Growth Hormone & I G F Research

published in

1 reference

3 May 2018

volume

13

1 reference

3 May 2018

page(s)

316-321

1 reference

3 May 2018

issue

6

1 reference

3 May 2018

Regulation and function of insulin-like growth factor-binding protein-1.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Insulin-like growth factor binding protein-1: recent findings and new directions.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Insulin-like growth factor-binding protein-1 modulates blood glucose levels

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Regulation of insulin-like growth factor binding protein-1 during protracted critical illness

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Expression of IGFBP-1 in normal and cirrhotic human livers

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Monoclonal antibodies to the 27-34K insulin-like growth factor binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Structure and localization of the IGFBP-1 gene and its expression during liver regeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Altered expression of members of the IGF-axis in hepatoblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Expression of IGF-I and IGF-binding protein genes in cirrhotic liver

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

In vivo insulin action in hepatocellular and cholestatic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Both insulin sensitivity and glucose sensitivity are impaired in patients with non-diabetic liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Twenty-four hour C-peptide and insulin secretion rates and diurnal profiles of glucose, lipids and intermediary metabolites in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Are patients with cirrhosis "glucose resistant"?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Mechanism of insulin resistance associated with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

The contribution of proinsulin and des-31,32 proinsulin to the hyperinsulinemia of diabetic and nondiabetic cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Alterations of glucose metabolism in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Diabetes increases the risk of acute hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

Issues of malnutrition and bone disease in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900042-X

7 January 2021

10.1016/S1096-6374(03)00042-X

Identifiers

DOI

1 reference

3 May 2018

PubMed ID

14624764

1 reference

3 May 2018